Andrew D Dickinson Gilead Sciences, Inc. (GILD) insider trading activity

Andrew D Dickinson is Chief Financial Officer of GILEAD SCIENCES, INC.. Currently has a direct ownership of 162,610 shares of GILD, which is worth approximately $17.7 Million. The most recent transaction as insider was on Jul 15, 2025, when has been sold 2,500 shares (Common Stock) at a price of $111.03 per share, resulting in proceeds of $277,575. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 163K

3.31% 3M change

18.73% 12M change

Total Value Held $17.7 Million

Andrew D Dickinson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 15 2025	SELL Open market or private sale	$277,575 $111.03 p/Share	2,500 Reduced 1.51%	162,610 Common Stock
Jun 16 2025	SELL Open market or private sale	$275,425 $110.17 p/Share	2,500 Reduced 1.49%	165,110 Common Stock
Jun 10 2025	SELL Payment of exercise price or tax liability	$193,538 $110.09 p/Share	1,758 Reduced 1.04%	167,610 Common Stock
Jun 10 2025	BUY Exercise of conversion of derivative security	-	3,694 Added 2.13%	169,368 Common Stock
May 15 2025	SELL Open market or private sale	$249,549 $99.82 p/Share	2,500 Reduced 1.49%	165,674 Common Stock
Apr 15 2025	SELL Open market or private sale	$266,000 $106.4 p/Share	2,500 Reduced 1.46%	168,174 Common Stock
Mar 17 2025	SELL Open market or private sale	$276,325 $110.53 p/Share	2,500 Reduced 1.44%	170,674 Common Stock
Mar 10 2025	SELL Open market or private sale	$2,113,829 $117.9 p/Share	17,929 Reduced 9.59%	169,061 Common Stock
Mar 10 2025	SELL Payment of exercise price or tax liability	$451,844 $117.21 p/Share	3,855 Reduced 2.18%	173,174 Common Stock
Mar 10 2025	BUY Exercise of conversion of derivative security	$1,655,077 $63.91 p/Share	25,897 Added 12.76%	177,029 Common Stock
Feb 18 2025	SELL Open market or private sale	$260,225 $104.09 p/Share	2,500 Reduced 1.46%	169,061 Common Stock
Feb 12 2025	SELL Open market or private sale	$14,073,240 $102.22 p/Share	137,676 Reduced 44.57%	171,223 Common Stock
Feb 12 2025	BUY Exercise of conversion of derivative security	$9,845,210 $71.51 p/Share	137,676 Added 30.83%	308,899 Common Stock
Feb 04 2025	SELL Payment of exercise price or tax liability	$4,227,092 $97.99 p/Share	43,138 Reduced 20.12%	171,223 Common Stock
Feb 04 2025	BUY Grant, award, or other acquisition	-	84,488 Added 28.27%	214,361 Common Stock
Jan 31 2025	SELL Open market or private sale	$13,822,739 $97.22 p/Share	142,180 Reduced 52.26%	129,873 Common Stock
Jan 31 2025	BUY Exercise of conversion of derivative security	$9,271,557 $65.21 p/Share	142,180 Added 34.24%	273,053 Common Stock
Jan 15 2025	SELL Open market or private sale	$228,375 $91.35 p/Share	2,500 Reduced 1.89%	129,873 Common Stock
Dec 16 2024	SELL Open market or private sale	$781,660 $91.96 p/Share	8,500 Reduced 6.03%	132,373 Common Stock
Dec 10 2024	SELL Payment of exercise price or tax liability	$155,685 $92.34 p/Share	1,686 Reduced 1.18%	140,873 Common Stock
Dec 10 2024	BUY Exercise of conversion of derivative security	-	3,640 Added 2.49%	142,559 Common Stock
Nov 29 2024	SELL Open market or private sale	$23,064,310 $92.76 p/Share	248,645 Reduced 64.16%	138,919 Common Stock
Nov 29 2024	BUY Exercise of conversion of derivative security	$17,310,664 $69.62 p/Share	248,645 Added 39.08%	387,564 Common Stock
Sep 10 2024	SELL Payment of exercise price or tax liability	$136,982 $81.44 p/Share	1,682 Reduced 1.2%	138,919 Common Stock
Sep 10 2024	BUY Exercise of conversion of derivative security	-	3,641 Added 2.52%	140,601 Common Stock

ADD

Andrew D Dickinson

Chief Financial Officer

Foster City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Value

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

Operation

Value

Type

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD

Account